Top news of the week: 14.06.2022.
Forbion raises $500M to back growing biotechs amid industry slump
The European venture firm’s latest fund will open up a new source of investment at a time companies are struggling to go public or hold their value.
A top cannabis and psychedelics investor predicts an 'existential crisis' ahead for startups and shares 2 key pieces of advice for founders
"When capital is easy to secure, entrepreneurial acumen goes untested," Ross O'Brien, Bonaventure Equity's managing partner, said.
Improving Disparity Begins with Us: Biotech Leaders Drive Diversity, Equity and Inclusion in Healthcare
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.
Are We Closer Than Ever to a Biotech Bottom?
Some observations point to hope for an upturn.
Harvard Professors Continue To Push Misconceptions To Justify Drug Price Controls
However, despite the millions of lives saved thanks to delivering both vaccines and therapeutics at equitable prices around the globe, this industry continues to get hammered by industry ...
Bluebird bio’s future in balance as FDA weighs gene therapy approvals
Once among biotech’s most valuable companies, Bluebird is running out of cash. Its fate could rest on the FDA’s review of two rare disease treatments, which are being discussed at a two-day ...
With New Funding, Phase Genomics Seeks to Eliminate One of Biology’s Biggest Blind Spots
Phase Genomics announces new funding from the Gates Foundation and the National Institute of Allergy and Infectious Diseases (NIAID)
Estimation of tumor cell total mRNA expression in 15 cancer types predicts disease progression
Total mRNA expression in cancer cells is a marker for disease progression and death.